Retatrutide
Retatrutide image 1Retatrutide image 2
GLP-1 PeptideStandardReport Available

Retatrutide

Research overview

<p> Retatrutide is a next-generation peptide engineered to target three major metabolic receptors — GIP, GLP-1, and glucagon — supporting advanced metabolic and body composition research. </p> <p> Public clinical investigations have demonstrated significant weight reduction potential, with trial participants reaching up to 17.5% body weight reduction within 24 weeks under controlled study conditions. </p> <p> Retatrutide research is commonly associated with appetite regulation, metabolic optimisation, insulin sensitivity pathways, and sustained fat metabolism analysis. </p> <p> This Vital Edge Science research batch features ultra-pure Retatrutide with 99.3%+ Janoshik-verified purity, supported by public batch verification and Australia/New Zealand fulfilment. </p> <p> Recommended for reconstitution using bacteriostatic water within a pH range of 5.7 to 7.0. </p> <p> Each vial contains 10mg~30mg of research-grade Retatrutide depending on selected variant. </p> <p> <strong>For research use only.</strong> </p>

Purity99.363%
Format10mg~30mg
Ships FromAustralia & New Zealand
MOQ1 vial

Available variants

10MG × 1$78.00In Stock
10MG × 10$532.00In Stock
15MG × 1$106.00In Stock
15MG × 10$887.00In Stock
20MG × 1$142.00In Stock
20MG × 10$1242.00In Stock
30MG × 1$213.00In Stock
30MG × 10$1768.00In Stock

Product description

<p> Retatrutide is a next-generation peptide engineered to target three major metabolic receptors — GIP, GLP-1, and glucagon — supporting advanced metabolic and body composition research. </p> <p> Public clinical investigations have demonstrated significant weight reduction potential, with trial participants reaching up to 17.5% body weight reduction within 24 weeks under controlled study conditions. </p> <p> Retatrutide research is commonly associated with appetite regulation, metabolic optimisation, insulin sensitivity pathways, and sustained fat metabolism analysis. </p> <p> This Vital Edge Science research batch features ultra-pure Retatrutide with 99.3%+ Janoshik-verified purity, supported by public batch verification and Australia/New Zealand fulfilment. </p> <p> Recommended for reconstitution using bacteriostatic water within a pH range of 5.7 to 7.0. </p> <p> Each vial contains 10mg~30mg of research-grade Retatrutide depending on selected variant. </p> <p> <strong>For research use only.</strong> </p>

Verification report

Report typeJanoshik / COA
Task number#101556
Unique ID4XI5S41HDDX9
Tested23 JAN 2026
Open reportRetatrutide COA